Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Using Arestat™ Technology

    NEXT STORY
    Global Medical Non-Woven Disposables Markets, 2019-2025
    PREV STORY
    Innate Pharma Provides Update from Regulatory Agencies on Lacutamab TELLOMAK Trial
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aptose Biosciences to Present at Canaccord Genuity 40th Annual Growth Conference

    author_avatar
    NASDAQ Market News

    Nabriva Therapeutics Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia

    - Lefamulin met all FDA and EMA primary endpoints  and was shown to be ...

    author_avatar
    NASDAQ Market News

    Biomica Announces Participation in the Microbiome Invest Conference in London May 23, 2018

    REHOVOT, Israel, May 14, 2018 (GLOBE NEWSWIRE) -- Biomica, a subsidiary of Evogene Ltd. ...

    author_avatar
    NASDAQ Market News